Novartis India Share Price

₹ 1,714.40

-₹3.30 (-0.19%)
1D
Last updated 03 Nov, 2026, 10:03 IST
NSE: NOVARTIND
|
Trading

Novartis India Share Price Today

As of 3 Nov 2026, Novartis India share price is ₹1,714.40. The stock opened at ₹1,739.00, compared to its previous close of ₹1,717.70. During today's trading session, Novartis India share price moved in the range of ₹1,672.50 to ₹1,744.10, with an average price of ₹1,708.30 for the day. Looking at its last 52-week, the stock has touched a low of ₹950.00 and a high of ₹2,588.80. On the performance front, Novartis India share price has increased by 66.69% over the last six months and is up 72.56% on a year-on-year basis.

Share price over the last 1 day fell from 1736.50 to 1714.40, ranging between 1708.30 and 1738.80.
₹1,672.50
0.19% down today
₹1,744.10
1D LOW
1D HIGH

Novartis India Stock Insights

Stock Performance
OutperformingBeat Nifty by 10.67 % in last 3 month
Shareholding Pattern
DIIDII increased stake by 10.08%
Shareholding Pattern
FIIFII increased stake by 685.67%
Novartis India stock performance
Open₹1,739.00
High₹1,744.10
Low₹1,672.50
Prev. close₹1,717.70
Novartis India trading activity
Volume7,821
Average traded price₹1,724.36
Last traded time10:03:35 03 Nov
Last traded quantity4
Circuit
L
H
₹1,374.20
₹2,061.20
52-week
L
H
₹950.00
₹2,588.80
Mkt Cap Cr
4,182.25
P/E
42.77
P/B
5.11
ROA
9.99%
ROE
11.39%
ROCE
15.94%
Quick Ratio
4.93
EV/EBITDA
25.34

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Novartis India has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Novartis India appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Novartis India Company Background

ISIN
INE234A01025
Sector Market Cap
₹ 4,182.25 Cr

Novartis India Limited is an India-based company. The Company is primarily engaged in the business of trading of Pharmaceuticals. It operates in the Pharmaceutical business segment. The Company’s brands hold key positions in therapeutic areas, such as, Voveran, which is the brand for bone and pain; Simulect, Certican, Sandimmun, Neoral, and Myfortic, which is the brand for transplantation immunology; and Tegrital and Exelon, which is the brand for neurosciences.

Novartis India Financial Highlights

  • Revenue: Novartis India reported revenue of ₹393.10 crore in FY26 vs ₹398.23 crore in FY25. It showed a decrease of 1.29% on a yearly basis.
  • Operating Profit: Novartis India reported an operating profit of ₹129.66 crore in FY26 vs ₹130.42 crore in FY25. It showed a decrease of 0.58% on a year-on-year basis.
  • Net Profit: Novartis India reported a net profit of ₹93.18 crore in FY26 vs ₹100.90 crore in FY25. It showed a decrease of 7.65% on a yearly basis.

Novartis India Quarterly Result Highlights

  • Novartis India reported revenue of ₹112.55 crore in Jun 2026, compared with ₹100.56 crore in Mar 2026, representing an increase of 11.92% on a quarter-on-quarter (QoQ) basis.
  • Novartis India reported an operating profit of ₹43.17 crore in Jun 2026, compared with ₹30.14 crore in Mar 2026, representing an increase of 43.23% on a quarter-on-quarter (QoQ) basis.
  • Novartis India reported a profit of ₹32.21 crore in Jun 2026, compared with ₹25.25 crore in Mar 2026, reflecting an increase of 27.56% on a QoQ basis.
  • The earnings per share (EPS) of Novartis India stood at ₹37.74 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
70.68%
FII
1.22%
Other DII
0.73%
Retail and other
26.60%
Mutual funds
0.77%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20260.17%
Jun 20260.16%
Jul 20260.15%
Sep 20261.22%

Novartis India Investment Returns

1 day
+1.49%
1 week
-4.05%
1 month
-12.59%
1 year
+72.56%
3 years
+72.56%
5 years
+128.42%

Novartis India Share Price History

Novartis India share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹1,709.00 / ₹1,717.70
+1.49%
30 Oct 26
₹1,802.00 / ₹1,692.40
-6.64%
29 Oct 26
₹1,834.00 / ₹1,812.80
-0.47%
28 Oct 26
₹1,836.00 / ₹1,821.40
-1.43%
Show more

Novartis India Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹354.33₹356.27₹335.07₹378.74
Other Income₹38.77₹41.96₹61.68₹58.11
Total Revenue₹393.10₹398.23₹396.75₹436.85
Total Expenses₹263.44₹267.81₹273.91₹321.47
Profit Before Tax₹129.66₹130.42₹122.84₹115.38
Tax₹36.48₹29.52₹37.65₹12.02
Profit After Tax₹93.18₹100.90₹85.19₹103.36
EPS - Basic₹37.74₹40.87₹34.50₹41.86
EPS - Diluted₹37.74₹40.87₹34.50₹41.86

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹129.66₹130.42₹122.84₹115.38
Income before WC changes₹95.90₹91.62₹66.09₹66.46
Change in Assets-₹11.08₹18.66₹21.49₹23.43
Change in Liabilities-₹2.83-₹19.42-₹12.45-₹47.43
Change in WC-₹13.91-₹0.76₹9.04-₹24.00
Cash flow from Operations₹46.73₹74.57₹113.40₹44.80
Cash flow from Investing₹17.63-₹3.31₹33.13-₹153.25
Cash flow from Financing-₹63.93-₹64.15-₹120.99-₹30.48
Total Cash Flow₹0.43₹7.11₹25.54-₹138.93
Cash (Start of the year)₹52.07₹44.96₹19.42₹158.35
Cash (End of the year)₹52.50₹52.07₹44.96₹19.42

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹210.02₹201.99₹225.67₹305.61
Current Assets₹768.25₹745.82₹699.26₹677.33
Total Assets₹978.27₹947.81₹924.93₹982.94
Current Liabilities₹144.97₹142.05₹157.20₹159.49
Net Current Asset₹623.28₹603.77₹542.06₹517.84
Non-Current Liabilities₹15.47₹20.80₹22.91₹47.79
Equity Capital₹817.83₹784.96₹744.82₹775.66
Total Equity & Liabilities₹978.27₹947.81₹924.93₹982.94
* All values are in INR Crore
Novartis India market depth
Bid quantityBid priceAsk priceAsk quantity
21712.41715.41
11712.31715.54
21712.11715.61
117121715.71
51711.81715.93
Total bid quantity11
Total ask quantity10
Novartis India technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
40.43
Neutral
ATR (14)
104.12
Neutral
STOCH(9,6)
29.71
Neutral
STOCH RSI (14)
30.64
Neutral
ADX(9)
33.65
Bearish
UO(9)
44.04
Neutral
ROC(12)
-13.61
Bearish
WillR(14)
-80.78
Bullish
Period
Simple value
Exponential vaue
5D
1778.42
1757.13
10D
1788.09
1797.52
20D
1888.88
1846.37
50D
1851.95
1831.04
100D
1687.73
2179.77
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Novartis India
Trading
Add Stock
Add Another

Novartis India Returns Calculator

Novartis India Latest News

1 month ago
Novartis India rallies for ninth session in a row, shares surge 74%; here is why
1 month ago
Novartis India shares surge 13%, hit fresh 52-week high on entering ophthalmology therapy
Showing news item 1 of 2

Top Gainers

TRIDENT Share Price
₹24.69
+2.48 (+11.17%)
KRBL Share Price
₹399.40
+36.4 (+10.03%)
GRSE Share Price
₹2206.00
+159.2 (+7.78%)
MARICO Share Price
₹853.55
+55 (+6.89%)
MOTILALOFS Share Price
₹1023.45
+59.05 (+6.12%)
See more

Top Losers

KEC Share Price
₹323.35
-25.65 (-7.35%)
GNFC Share Price
₹480.10
-30.9 (-6.05%)
PRAJIND Share Price
₹259.62
-11.51 (-4.25%)
GESHIP Share Price
₹1549.90
-50.5 (-3.16%)
BALAMINES Share Price
₹1760.60
-50.4 (-2.78%)
See more

Novartis India Share Price FAQs

Please be aware that Novartis India stock prices are subject to continuous fluctuations due to various factors.